Mouse Anti-OIP5 Recombinant Antibody (CBXO-0043) (CBMAB-O0344-CQ)

Hiura, K., Watanabe, M., Hirose, N., Nakano, K., Okamura, T., Sasaki, H., & Sasaki, N. (2024). Mitotic Spindle Positioning (MISP) Facilitates Colorectal Cancer Progression by Forming a Complex with Opa Interacting Protein 5 (OIP5) and Activating the JAK2-STAT3 Signaling Pathway. International Journal of Molecular Sciences, 25(5), 3061.

Zhu, M., Takano, A., Tsevegjav, B., Yoshitake, Y., Shinohara, M., & Daigo, Y. (2022). Characterization of Opa interacting protein 5 as a new biomarker and therapeutic target for oral cancer. International Journal of Oncology, 60(3), 1-11.

Shi, C., Zhang, H., Wang, M., Tian, R., Li, X., Feng, Y., ... & Qin, R. (2022). OPA interacting protein 5 antisense RNA 1 expedites cell migration and invasion through FOXM1/Wnt/β-catenin pathway in pancreatic cancer. Digestive Diseases and Sciences, 1-10.

Zhang, L., Cai, Y., Tian, C., Li, Y., Ma, K., Gao, X., ... & Ma, Z. (2022). LncRNA Opa interacting protein 5‐antisense RNA 1 (OIP5‐AS1) promotes the migration, invasion and epithelial‐mesenchymal transition (EMT) through targeting miR‐147a/insulin‐like growth factor 1 receptor (IGF1R) pathway in cervical cancer tissues and cell model. Journal of Obstetrics and Gynaecology Research, 48(5), 1222-1232.

Chen, L., Wang, R., Gao, L., & Shi, W. (2020). Opa-interacting protein 5 expression in human glioma tissues is essential to the biological function of u251 human malignant glioma cells. Cancer Control, 27(1), 1073274820968914.

Liang, J., Tian, X. F., & Yang, W. (2020). Effects of long non-coding RNA Opa-interacting protein 5 antisense RNA 1 on colon cancer cell resistance to oxaliplatin and its regulation of microRNA-137. World Journal of Gastroenterology, 26(13), 1474.

Yang, J., Jiang, B., Hai, J., Duan, S., Dong, X., & Chen, C. (2019). Long noncoding RNA opa‐interacting protein 5 antisense transcript 1 promotes proliferation and invasion through elevating integrin α6 expression by sponging miR‐143‐3p in cervical cancer. Journal of cellular biochemistry, 120(1), 907-916.

Li, Y., Xiao, F., Li, W., Hu, P., Xu, R., Li, J., ... & Zhu, C. (2019). Overexpression of Opa interacting protein 5 increases the progression of liver cancer via BMPR2/JUN/CHEK1/RAC1 dysregulation. Oncology Reports, 41(4), 2075-2088.

Chen, X., Xiong, D., Yang, H., Ye, L., Mei, S., Wu, J., ... & Huang, L. (2019). Long noncoding RNA OPA‐interacting protein 5 antisense transcript 1 upregulated SMAD3 expression to contribute to metastasis of cervical cancer by sponging miR‐143‐3p. Journal of cellular physiology, 234(4), 5264-5275.

Please try the standard protocols which include: protocols, troubleshooting and guide.

Enzyme-linked Immunosorbent Assay (ELISA)
Flow Cytometry
Immunofluorescence (IF)
Immunohistochemistry (IHC)
Immunoprecipitation (IP)
Western Blot (WB)
Enzyme-Linked Immunospot (ELISpot)
Proteogenomics
Other Protocols